Breeze Meds vs Willow: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Willow beats Breeze Meds overall, scoring 8.2/10 vs 7.3/10. Breeze Meds is more affordable at $199/mo vs $299/mo. Choose Breeze Meds for users who want a straightforward compounded glp-1 program wi. Choose Willow for users who want comprehensive clinical support with flexibili.
A side-by-side comparison of Breeze Meds and Willow covering pricing, scores, medication types, insurance, and more to help you decide.
Breeze Meds
#34 of 48Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.
Visit Breeze MedsWillow
#8 of 48Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only — Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.
Visit Willow| Feature | Breeze Meds | Willow |
|---|---|---|
| Our Score | 7.3/10 | 8.2/10 |
| Starting Price | $199/mo | $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a straightforward compounded GLP-1 program with fast shipping | Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes |
| Ranking | #34 | #8 |
Pros & Cons Compared
Breeze Meds
Pros
- +No subscription required — order on demand without recurring billing commitments
- +Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
- +FSA/HSA eligible for those with health savings accounts
- +Discreet packaging on all shipments
Cons
- −Very limited independent reviews and unclear company structure — legitimacy is hard to verify
- −Oral options at $299-399/mo are significantly more expensive than injectable alternatives
- −Not available in all 50 states — varies by provider licensure in your state
Willow
Pros
- +Includes monthly provider check-ins and dose adjustments at no extra cost
- +Offers both injectable AND oral compounded semaglutide — one of few platforms with a daily oral tablet option
- +$299/mo all-in for compounded semaglutide with monthly provider support
- +90%+ patient retention rate after 3 months per their published outcomes data
Cons
- −Compounded-only — no brand-name Wegovy or Zepbound through the platform
- −Tirzepatide pricing reaches $499-$524 at higher doses — starting dose is $399/mo
- −Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
- −Founded in 2024 — less track record than Ro or Hims, though growth has been fast
Our Verdict
Willow edges out Breeze Meds with a score of 8.2/10 vs 7.3/10. If budget is your priority, Breeze Meds starts at $199/mo compared to Willow's $299/mo. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.
Still undecided? Editor's #1 Overall Pick
Eden Health GLP-1
$249/mo · 8.9/10 · Both
If neither Breeze Meds nor Willow feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.
Read Full Reviews
Related comparisons
Other matchups readers comparing Breeze Meds or Willow tend to look at next.
- Breeze Meds vs MyStart Health$299/mo
- Breeze Meds vs Direct Meds GLP-1$297/mo
- Breeze Meds vs DudeMeds$149/mo
- Willow vs MyStart Health$299/mo
- Willow vs Direct Meds GLP-1$297/mo
- Willow vs DudeMeds$149/mo